BANGKOK - Thailand looked like it was ahead in the regional scramble for a coronavirus vaccine in October when it announced a local firm would manufacture the Oxford-AstraZeneca vaccine for domestic use and distribution to nearby countries.
But with a locally-produced vaccine months away while local transmissions grew over the new year, Thailand sought to boost its initial reservation of 26 million doses. It ordered 35 million more, and supplemented that with two million doses of vaccine from China's Sinovac Biotech. The first batches of British and Chinese-made vaccines are expected to arrive next month.
Already a subscriber? Log in
Read the full story and more at $9.90/month
Get exclusive reports and insights with more than 500 subscriber-only articles every month
ST One Digital
$9.90/month
No contract
ST app access on 1 mobile device
Unlock these benefits
All subscriber-only content on ST app and straitstimes.com
Easy access any time via ST app on 1 mobile device
E-paper with 2-week archive so you won't miss out on content that matters to you
